Related Experiment Videos
The Charcot foot in diabetes
Lee C Rogers1, Robert G Frykberg, David G Armstrong
1Amputation Prevention Center at Valley Presbyterian Hospital, Los Angeles, CA, USA. lee.c.rogers@gmail.com
Journal of the American Podiatric Medical Association
|September 30, 2011
Summary
Diabetic Charcot foot syndrome, a serious complication of diabetes, involves bone and joint disorganization due to neuropathy and metabolic issues. Experts convened to review evidence on its causes, progression, and treatments.
Area of Science:
- Podiatry
- Endocrinology
- Diabetic Complications
Background:
- Diabetic Charcot foot syndrome is a severe lower-extremity complication of diabetes, characterized by bone and joint disorganization.
- It arises from neuropathy, trauma, and altered bone metabolism, presenting a diagnostic and therapeutic challenge.
- The condition is now understood as an inflammatory syndrome.
Purpose of the Study:
- To summarize current evidence on the pathophysiology, natural history, clinical presentations, and treatment of diabetic Charcot foot syndrome.
- To provide a comprehensive overview for practitioners managing this complex condition.
- To consolidate expert consensus on this enigmatic diabetic complication.
Main Methods:
- Convening an international task force of experts.
- Reviewing and synthesizing available scientific evidence.
- Compiling recommendations based on expert consensus and evidence.
Main Results:
- The syndrome involves inflammatory processes contributing to bone and joint destruction.
- Understanding the interplay of neuropathy, trauma, and bone metabolism is crucial.
- Evidence-based treatment strategies are being developed.
Conclusions:
- Diabetic Charcot foot syndrome requires a multidisciplinary approach for effective management.
- Early diagnosis and intervention are key to preventing severe deformity and amputation.
- Continued research is needed to further elucidate the pathophysiology and optimize treatment outcomes.
Related Concept Videos
Diabetic Foot Ulcer
Definition A diabetic foot ulcer (DFU) is a chronic, non-healing wound that develops in individuals with diabetes. It typically occurs on pressure-bearing areas such as the heel, metatarsal heads, or hallux, and carries a high risk of infection and amputation.Pathophysiology • The development of DFUs can be explained by four interconnected mechanisms: neuropathy, ischemia, infection, and impaired wound healing. • Neuropathy is the most common factor. Sensory neuropathy reduces pain perception,...
Diabetic Neuropathy
DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
Complications of Diabetes Mellitus
Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...
Pathophysiology of Diabetes
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...